372 related articles for article (PubMed ID: 17661004)
1. [Comparison of perioperative methylene blue-stained and permanent Papanicolaou-stained urine cytology to detect patients with high-grade urothelial cancer or the urinary bladder. Part 1].
Rossi R; Jaeger T; Börgermann C; Furtkamp C; Moos Stahl R; Rübben H; vom Dorp F
Urologe A; 2007 Sep; 46(9):1145-7. PubMed ID: 17661004
[TBL] [Abstract][Full Text] [Related]
2. [Various staining procedures in exfoliative urine cytology. Use in routine urology].
Rübben H; Terhorst B; Deutz FJ; Lagrange W; Giani G
Urologe A; 1986 Sep; 25(5):302-4. PubMed ID: 2431532
[TBL] [Abstract][Full Text] [Related]
3. A Novel Urine-Based Assay for Bladder Cancer Diagnosis: Multi-Institutional Validation Study.
Davis N; Shtabsky A; Lew S; Rona R; Leibovitch I; Nativ O; Cohen M; Mor Y; Lindner U; Glickman Y; Matzkin H; Tsivian A; Gofrit O; Yossepovitch O
Eur Urol Focus; 2018 Apr; 4(3):388-394. PubMed ID: 28753799
[TBL] [Abstract][Full Text] [Related]
4. Does subdivision of the "atypical" urine cytology increase predictive accuracy for urothelial carcinoma?
Bostwick DG; Hossain D
Diagn Cytopathol; 2014 Dec; 42(12):1034-44. PubMed ID: 24838797
[TBL] [Abstract][Full Text] [Related]
5. Cytokeratin 20 immunocytochemistry on urine sediments: A potential low-cost adjunct to cytology in the diagnosis of low-grade urothelial carcinoma.
Wadhwa N; Diwaker P; Lotha N; Arora VK; Singh N
Cytopathology; 2017 Dec; 28(6):531-535. PubMed ID: 28940433
[TBL] [Abstract][Full Text] [Related]
6. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
[TBL] [Abstract][Full Text] [Related]
7. Quick-staining urinary cytology and bladder wash image analysis with an integrated risk classification: a worthwhile improvement in the follow-up of bladder cancer?
Wiener HG; Remkes GW; Schatzl G; Susani M; Breitenecker G
Cancer; 1999 Oct; 87(5):263-9. PubMed ID: 10536351
[TBL] [Abstract][Full Text] [Related]
8. p16/Ki-67 dual labeling and urinary cytology results according to the New Paris System for Reporting Urinary Cytology: Impact of extended follow-up.
Piaton E; Advenier AS; Carré C; Decaussin-Petrucci M; Mège-Lechevallier F; Hutin K; Nennig C; Colombel M; Ruffion A
Cancer Cytopathol; 2017 Jul; 125(7):552-562. PubMed ID: 28371465
[TBL] [Abstract][Full Text] [Related]
9. Reclassification of urinary cytology regarding The Paris System for Reporting Urinary Cytology with cytohistological correlation demonstrates high sensitivity for high-grade urothelial carcinoma.
Anbardar MH; Monjazeb R
Diagn Cytopathol; 2020 May; 48(5):446-452. PubMed ID: 31976626
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of semaphorin 3A in patients with urothelial cancer.
Vadasz Z; Rubinstein J; Bejar J; Sheffer H; Halachmi S
Urol Oncol; 2018 Apr; 36(4):161.e1-161.e6. PubMed ID: 29288007
[TBL] [Abstract][Full Text] [Related]
11. Detection of urinary bladder cancer with flow cytometry and hexaminolevulinate in urine samples.
Cunderlíková B; Wahlqvist R; Berner A; Vasovic V; Warloe T; Nesland JM; Peng Q
Cytopathology; 2007 Apr; 18(2):87-95. PubMed ID: 17397493
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
[TBL] [Abstract][Full Text] [Related]
13. The cytomorphological features of low-grade urothelial neoplasms vary by specimen type.
Zhang ML; Rosenthal DL; VandenBussche CJ
Cancer Cytopathol; 2016 Aug; 124(8):552-64. PubMed ID: 27019161
[TBL] [Abstract][Full Text] [Related]
14. Polyomavirus infection and urothelial carcinoma.
Loghavi S; Bose S
Diagn Cytopathol; 2011 Jul; 39(7):531-5. PubMed ID: 20891007
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical staining for p53 and Ki-67 helps to characterise urothelial cells in urine cytology.
Courtade-Saïdi M; Aziza J; d'Aure D; Bérard E; Evrard S; Basset C; Lacoste-Collin L
Cytopathology; 2016 Dec; 27(6):456-464. PubMed ID: 27873391
[TBL] [Abstract][Full Text] [Related]
16. Positive urine cytology and carcinoma in situ prior to second transurethral resection of the bladder correlate with positive second resection histology and the need for subsequent cystectomy.
Lodde M; Mayr R; Martini T; Comploj E; Palermo S; Trenti E; Hanspeter E; Fritsche HM; Mian C; Pycha A
World J Urol; 2012 Dec; 30(6):841-6. PubMed ID: 23143733
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of preoperative urinary smear test in patients with bladder urothelial carcinoma in a high-volume center.
Restrepo-Gonzalez JA; Garcia-Perdomo HA; Varela R
Arch Esp Urol; 2014 Apr; 67(3):243-8. PubMed ID: 24840589
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma.
Veeramachaneni R; Nordberg ML; Shi R; Herrera GA; Turbat-Herrera EA
Diagn Cytopathol; 2003 Jun; 28(6):301-7. PubMed ID: 12768634
[TBL] [Abstract][Full Text] [Related]
19. [The value of urinary cytology in the diagnosis of high grade urothelial tumors].
Niedworok C; Rembrink V; Hakenberg OW; Börgermann C; Rossi R; Schneider T; Becker M; Szarvas T; von Ostau C; Swoboda A; Rübben H; vom Dorp F
Urologe A; 2009 Sep; 48(9):1018, 1020-2, 1024. PubMed ID: 19697005
[TBL] [Abstract][Full Text] [Related]
20. An institutional experience with The Paris System: A paradigm shift from ambiguous terminology to more objective criteria for reporting urine cytology.
Roy M; Kaushal S; Jain D; Seth A; Iyer VK; Mathur SR
Cytopathology; 2017 Dec; 28(6):509-515. PubMed ID: 28833848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
